The invention relates to novel pyrimidothienoindazoles of formula (I) ##STR00001## processes for their preparation and their use for preparing medicaments for the treatment or prophylaxis of disorders, especially of hyperproliferative disorders.
This application claims benefit of U.S. Provisional Application Ser. No. 60/622,640; filed on Oct. 27, 2004, the content of which is incorporated herein by reference in its entirety.
